Pertussis before, during and after Covid-19
Author:
Open Access
- 24 February 2025
- journal article
- review article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (4) , 594-598
Abstract
After the Covid-19 pandemic, pertussis has made a spectacular comeback in Europe and many other parts of the world, while during the pandemic it had essentially disappeared because of the social distancing requirements. However, even before the Covid-19 pandemic, the disease was on the rise in many countries, especially those that have replaced whole-cell pertussis vaccines by acellular pertussis vaccines. Several reasons may account for this upsurge, including strain adaptation to escape vaccine-induced immunity, rapid waning of immunity after vaccination and the failure of current vaccines to prevent infection by and transmission of the causative agent Bordetella pertussis . Various strategies have been deployed to control the disease, the most effective of which is maternal vaccination during pregnancy to protect the newborn against the most severe and deadly forms of the disease. However, ultimate control of pertussis likely requires novel vaccines, which prevent infection and transmission, not only disease. One of them is the live attenuated BPZE1 vaccine, which has shown promise in pre-clinical and clinical studies and may therefore perhaps become a gamechanger.Keywords
This publication has 35 references indexed in Scilit:
- Evaluation of the Impact of a Pertussis Cocooning Program on Infant Pertussis InfectionThe Pediatric Infectious Disease Journal, 2015
- Effectiveness of maternal pertussis vaccination in England: an observational studyThe Lancet, 2014
- A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male VolunteersPLOS ONE, 2014
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate modelProceedings of the National Academy of Sciences, 2013
- Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease ProtectionJAMA, 2012
- Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping CoughPLOS Pathogens, 2006
- Duration of Immunity Against Pertussis After Natural Infection or VaccinationThe Pediatric Infectious Disease Journal, 2005
- Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell ResponsesThe Journal of Immunology, 2003
- Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunityInfection and Immunity, 1993
- Directly Transmitted Infections Diseases: Control by VaccinationScience, 1982